MAPT and Alzheimer disease: The use of CPRD Medcodes also may provide a poor estimate of the proportion of patients with AD because nonspecific Medcodes are often used in primary care for suspected dementia and these can be misapplied.42 In addition, the diagnosis of AD was not confirmed by CSF biomarkers such as Aβ and tau protein.